Profile data is unavailable for this security.
About the company
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company provides biological products, traditional Chinese medicines and chemical supplements, applied in the treatment of diabetes and cardiovascular and cerebrovascular diseases, among others. The Company's main products portfolio consists of recombinant human insulin bulk drugs and injections, zhennaoning capsules, among others. The Company also provides medical instruments, plastic-steel windows and profiles, and operates property business. The Company distributes its products within domestic markets and to overseas markets.
- Revenue in CNY (TTM)2.45bn
- Net income in CNY452.54m
- Incorporated1992
- Employees3.20k
- LocationTonghua Dongbao Pharmaceutical Co LtdDongbao New Village, Tonghua CountyTONGHUA 134123ChinaCHN
- Phone+86 4 355088025
- Fax+86 4 355088002
- Websitehttp://www.thdb.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liaoning Cheng Da Co Ltd | 11.50bn | 195.93m | 12.59bn | 3.36k | 66.00 | 0.4262 | -- | 1.10 | 0.1247 | 0.1247 | 7.49 | 19.31 | 0.2399 | 5.11 | 6.34 | 3,425,308.00 | -0.043 | 3.59 | -0.0613 | 5.21 | 15.12 | 14.15 | -0.1791 | 9.89 | 0.9012 | -- | 0.3102 | 15.93 | -25.97 | -10.97 | -80.95 | -21.26 | 7.04 | -- |
| Shanghai Shyndec Pharmaceutical Co Ltd | 11.59bn | 1.07bn | 13.63bn | 11.61k | 12.79 | 1.05 | -- | 1.18 | 0.7945 | 0.7945 | 8.64 | 9.67 | 0.5953 | 3.17 | 6.50 | 998,061.50 | 6.87 | 4.85 | 10.06 | 8.17 | 37.32 | 43.00 | 11.54 | 7.03 | 1.97 | -- | 0.104 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
| Tonghua Dongbao Pharmaceutical Co Ltd | 2.45bn | 452.54m | 14.27bn | 3.20k | 34.27 | 2.20 | -- | 5.83 | 0.2101 | 0.2101 | 1.25 | 3.28 | 0.3527 | 0.697 | 4.25 | 766,304.10 | 6.51 | 18.68 | 6.85 | 19.68 | 78.80 | 78.73 | 18.47 | 39.20 | 3.07 | -- | 0.0524 | 41.73 | 10.69 | 2.69 | -26.17 | 6.85 | -14.75 | 4.56 |
| Zhejiang Medicine Co., Ltd. | 8.26bn | 472.71m | 14.42bn | 6.23k | 29.90 | 1.45 | -- | 1.75 | 0.5017 | 0.5017 | 8.72 | 10.34 | 0.6455 | 2.81 | 6.18 | 1,326,750.00 | 2.70 | 4.32 | 3.41 | 5.68 | 32.28 | 36.57 | 4.18 | 6.28 | 1.77 | 3.64 | 0.0755 | 58.72 | -3.96 | 2.59 | -20.37 | 3.34 | 12.65 | 0.00 |
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 407.21m | -230.89m | 15.59bn | 867.00 | -- | 9.95 | -- | 38.28 | -0.8669 | -0.8669 | 1.53 | 5.92 | 0.1364 | 0.2484 | 3.38 | 469,674.00 | -8.44 | -27.13 | -13.16 | -39.20 | 92.31 | 92.75 | -61.85 | -220.71 | 2.19 | -- | 0.3791 | -- | 27.83 | 211.81 | 39.08 | -- | 41.38 | -- |
Data as of Sep 20 2024. Currency figures normalised to Tonghua Dongbao Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
7.97%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Abu Dhabi Investment Authority (Investment Management)as of 25 Jul 2024 | 31.84m | 1.59% |
| China Merchants Fund Management Co., Ltd.as of 25 Jul 2024 | 22.55m | 1.13% |
| Harvest Fund Management Co., Ltd.as of 25 Jul 2024 | 19.19m | 0.96% |
| China Southern Asset Management Co., Ltd.as of 25 Jul 2024 | 18.95m | 0.95% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 13.08m | 0.65% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 12.30m | 0.61% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 11.68m | 0.58% |
| Yinhua Fund Management Co., Ltd.as of 25 Jul 2024 | 11.66m | 0.58% |
| Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 9.61m | 0.48% |
| HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 8.86m | 0.44% |
More ▼
Data from 31 Dec 2023 - 03 Sep 2024Source: FactSet Research Systems Inc.
